clinical trial - HealthQuill

Daiichi Sankyo will buy outright a cancer antibody it had licensed from Glycotope GmbH earlier for $132.5 million, according to a statement from the Japanese company.

Daiichi Sankyo to buy cancer antibody from Glycotope for $132.5 million

Daiichi Sankyo will buy outright a cancer antibody it had licensed from Glycotope GmbH earlier for $132.5 million, according to a statement from.

by HealthQuill
January 15, 2025
0 Comments

Drugs Health Pharma

Ketamine pill may revolutionize treatment for hard-to-treat depression

HQ Team October 25, 2024: A recent study indicates that a new slow-release ketamine pill could offer a promising alternative for individuals suffering.

by HealthQuill
October 25, 2024
0 Comments

British drugmaker, GSK Plc.’s multiple myeloma drug, Blenrep, reduced the risk of disease progression or death by about 50% when compared to a standard-of-care combination, according to the company.

Drugs Health Medical

New CAR T-cell therapy offers hope for children with aggressive blood cancer

HQ Team October 14, 2024: Children with aggressive blood cancer may soon have access to a new treatment, CAR T-cell therapy, targeting T-cell.

by HealthQuill
October 14, 2024
0 Comments

Genentech, a member of the Roche Group, will acquire a portfolio of CDK inhibitors to treat breast cancer from Regor Pharmaceuticals for an upfront payment of $850 million.

Drugs Health Pharma

Roche arm to buy breast cancer portfolio from Regor for $850 million

Genentech, a member of the Roche Group, will acquire a portfolio of CDK inhibitors to treat breast cancer from Regor Pharmaceuticals for an.

by HealthQuill
September 30, 2024
0 Comments

Shanghai Henlius Biotech, Inc., and US-based Organon & Co. announced their end-stage trial for investigational breast cancer had met its main goal of an absence of cancer in treated patients.

Drugs Health Pharma

Henlius, Organon trial drug meets goal of an absence of breast cancer

Shanghai Henlius Biotech, Inc., and US-based Organon & Co. announced their end-stage trial for investigational breast cancer had met its main goal of.

by HealthQuill
September 30, 2024
0 Comments

Drugs Health Medical

Breakthrough gene therapy restores hearing in children with inherited deafness

HQ Team August15, 2024: A clinical trial has successfully restored hearing in five children suffering from inherited deafness by administering gene therapy to.

by HealthQuill
August 15, 2024
0 Comments

The US-based Merck and Co.’s investigational medicine to protect infants from respiratory syncytial virus (RSV) disease has resulted in lowering infections, according to the company.

Drugs Health Pharma

Merck’s experimental RSV injection lowers infections in infants

The US-based Merck and Co.’s investigational medicine to protect infants from respiratory syncytial virus (RSV) disease has resulted in lowering infections, according to.

by HealthQuill
July 24, 2024
0 Comments

Sixty percent of the patients treated with Pfizer’s Lorbrena drug, for a rare form of advanced lung cancer, were alive without disease progression after five years, according to company data.

Drugs Health Pharma

Pfizer’s drug helps people with rare lung cancer live longer, data shows

Sixty percent of the patients treated with Pfizer’s Lorbrena drug, for a rare form of advanced lung cancer, were alive without disease progression.

by HealthQuill
June 1, 2024
0 Comments

Synchron, a US-based brain implant company, plans to recruit motor-impaired patients for its clinical trial in competition with Elon Musk’s Neurolink.

Drugs Health Pharma

Rivalling Elon Musk’s Neuolink, Synchron plans brain implant trial

HQ Team April 9, 2024: Synchron, a US-based brain implant company, plans to recruit motor-impaired patients for its clinical trial in competition with.